On October 16, The Gateway Pundit ran a sponsored “Promoted Post” selling The Wellness Company’s REGENERATE, oral drops of BPC-157, TB-500 and KPV listed at $299.99. It ran a day after AP reported a federal plan to ease peptide compounding. The headline sells a secret before it names a product. Its subject is “Big Pharma”, with no company, no act and no date, and the only thing said of it is that it has been “sitting on” something. That is the hint: a charge no one ever has to prove, and the reader supplies the rest. Only the third paragraph names the seller, The Wellness Company, and the product, REGENERATE, listed at $299.99, or $269.99 on a subscription. The line rides the proof you wanted: a reader who already distrusts drug companies is told the distrust was right, and handed a bottle as the evidence. The evidence on the page is two customer stories. What the FDA says came a day earlier, in AP’s report: BPC-157 was on its list of substances too risky for pharmacies to compound, most peptide data comes from animal studies, and the risks include “tumor growth”. The seller’s own page tells anyone who has had cancer to consult a professional before use. The ad ran the morning after AP reported that HHS sent the White House a plan to let pharmacies temporarily compound popular peptides, BPC-157 among them. Newsweek’s opinion page, three minutes earlier, asked for “Proof, Not Promises”. The copy itself is older: largely the same text ran on The Burning Platform on March 26 under another secret Big Pharma “Doesn’t Want You to Know About”. The tell to keep: a headline that names an enemy and a secret but no product has its price further down.
